1198 Cytokine affinity tuning and antibody discovery/optimization using the AlphaSeq and AlphaBind platforms to generate targeted immuno-oncology therapeutics

• Ryan Swanson,
• John Marken,
• Davis Goodnight,
• Kimberly Wellman,
• Jeff Adamo,
• Emily Engelhart,
• Oliver Serang,
• Aditya Agarwal,
• Cameron Cordray,
• Samer Halabiya,
• Kyle Minch,
• Randolph Lopez

Affiliations

Ryan Swanson

A-Alpha Bio, Inc., Seattle, WA, USA

John Marken

A-Alpha Bio, Inc., Seattle, WA, USA

Davis Goodnight

A-Alpha Bio, Inc., Seattle, WA, USA

Kimberly Wellman

A-Alpha Bio, Inc., Seattle, WA, USA

Jeff Adamo

A-Alpha Bio, Inc., Seattle, WA, USA

Emily Engelhart

A-Alpha Bio, Inc., Seattle, WA, USA

Oliver Serang

A-Alpha Bio, Inc., Seattle, WA, USA

Aditya Agarwal

A-Alpha Bio, Inc., Seattle, WA, USA

Cameron Cordray

A-Alpha Bio, Inc., Seattle, WA, USA

Samer Halabiya

A-Alpha Bio, Inc., Seattle, WA, USA

Kyle Minch

A-Alpha Bio, Inc., Seattle, WA, USA

Randolph Lopez

A-Alpha Bio, Inc., Seattle, WA, USA